Amit Akirov, MD, Author at Pulmonology Advisor

Targeting Chronic Obstructive Pulmonary Disease Endotypes

By

Amit Akirov, MD

February 16, 2021

This review of current literature discusses emerging therapies directed at COPD endotypes and pathobiological processes that manifest as the disease.

COPD Advisor Channel

The Need for New Biological Targets for Therapeutic Intervention in COPD

By

Amit Akirov, MD

January 28, 2021

Chronic obstructive pulmonary disease (COPD) continues to be a major cause of disability and is one of the leading causes of mortality worldwide. Here, we summarize COPD pathology, available treatment options and additional potential pathways and targets for new therapeutic development.

Lung Infection

Neuropathological Changes in Autopsied Brain Tissue of Patients With COVID-19

By

Amit Akirov, MD

November 20, 2020

Neuropathological changes in patients with coronavirus disease 2019 are relatively mild, with neuroinflammatory changes in the brain stem most often found.

Asthma

Asthma Is Associated With Increased Risk for Osteoporosis

By

Amit Akirov, MD

October 8, 2020

Researchers analyzed the association of asthma and its subgroups with osteoporosis in the Korean adult population, and determined the effects of asthma on osteoporosis based on condition of asthma management.

COPD

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life

By

Amit Akirov, MD

September 22, 2020

Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.